| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $6.2B | $6.4B | $6.3B | $6.2B | $6.3B |
| Cost of Revenue | $2.9B | $2.7B | $2.5B | $2.3B | $2.4B |
| Gross Profit | $3.3B | $3.7B | — | — | — |
| R&D Expense | — | — | — | — | $0.4B |
| SG&A Expense | $1.7B | $1.8B | $1.9B | $1.7B | $1.7B |
| Operating Income | — | — | — | — | — |
| Net Income | $0.2B | $0.9B | $1.0B | $0.9B | $1.4B |
| EPS (Basic) | $0.72 | $3.36 | $4.01 | $3.61 | $5.33 |
| EPS (Diluted) | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $12.9B | $13.1B | $12.1B | $11.0B | $10.7B |
| Current Assets | $4.4B | $4.3B | $4.5B | $3.9B | $3.8B |
| Cash & Equivalents | $0.6B | $0.7B | $0.7B | $0.7B | $0.7B |
| Total Liabilities | $12.1B | $12.6B | $12.1B | — | — |
| Current Liabilities | $2.4B | $2.7B | $2.9B | $2.5B | $2.6B |
| Stockholders' Equity | $0.8B | $0.5B | $-0.1B | $-0.9B | $-1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.9B | — | — | — |
| Investing Cash Flow | $-0.4B | $-0.5B | — | — | — |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.6B | $-0.4B | — | — | — |